German Inclisiran Network: Retrospective Registry of Patients Being Treated With the siRNA Inclisiran in Germany

Jena University Hospital500 enrolled

Overview

The German Inclisiran Network is a registry of patients with hypercholesterinemia on treatment with the siRNA inclisiran in Germany

The aim of this retrospective, multi-center analysis is to use individual patient data to determine the extent of the variability in LDL-C reduction in response to inclisiran administration in a real-world setting.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Hypercholesterolemia

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * patients with elevated LDL-C levels (hypercholesterolemia) on stable lipid-lowering drugs for at least one month prior to the application of the siRNA Inclisiran * patients 18 years and older Exclusion Criteria: \- patients who do not qualify for treatment with the siRNA inclisiran according to the G-BA (Gemeinsamer Bundesausschuß) in Germany.

Locations (1)

Jena University Hospital

Jena, Germany

RECRUITING

Outcomes

Primary Outcomes

LDL-C change

LDL-C change in mg/dL / mmol/L

Time frame: 3 months, 6 months, 12 months, 24 months

Central Contacts

Oliver Weingaertner, MD

CONTACT

+4936419324521 oliver.weingaertner@med.uni-jena.de

Martin Foerster, PhD

CONTACT

+4936419325818 martin.foerster@med.uni-jena.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.